174 related articles for article (PubMed ID: 34890156)
1. De novo Prediction of Cell-Drug Sensitivities Using Deep Learning-based Graph Regularized Matrix Factorization.
Ren S; Tao Y; Yu K; Xue Y; Schwartz R; Lu X
Pac Symp Biocomput; 2022; 27():278-289. PubMed ID: 34890156
[TBL] [Abstract][Full Text] [Related]
2. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Drug Response Prediction in Cell Lines Using Weighted Graph Regularized Matrix Factorization.
Guan NN; Zhao Y; Wang CC; Li JQ; Chen X; Piao X
Mol Ther Nucleic Acids; 2019 Sep; 17():164-174. PubMed ID: 31265947
[TBL] [Abstract][Full Text] [Related]
4. Deep learning and multi-omics approach to predict drug responses in cancer.
Wang C; Lye X; Kaalia R; Kumar P; Rajapakse JC
BMC Bioinformatics; 2022 Nov; 22(Suppl 10):632. PubMed ID: 36443676
[TBL] [Abstract][Full Text] [Related]
5. SWnet: a deep learning model for drug response prediction from cancer genomic signatures and compound chemical structures.
Zuo Z; Wang P; Chen X; Tian L; Ge H; Qian D
BMC Bioinformatics; 2021 Sep; 22(1):434. PubMed ID: 34507532
[TBL] [Abstract][Full Text] [Related]
6. How much can deep learning improve prediction of the responses to drugs in cancer cell lines?
Chen Y; Zhang L
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34529029
[TBL] [Abstract][Full Text] [Related]
7. DBDNMF: A Dual Branch Deep Neural Matrix Factorization method for drug response prediction.
Liu H; Wang F; Yu J; Pan Y; Gong C; Zhang L; Zhang L
PLoS Comput Biol; 2024 Apr; 20(4):e1012012. PubMed ID: 38574114
[TBL] [Abstract][Full Text] [Related]
8. Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.
Pang W; Chen M; Qin Y
BMC Bioinformatics; 2024 May; 25(1):182. PubMed ID: 38724920
[TBL] [Abstract][Full Text] [Related]
9. Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.
Emdadi A; Eslahchi C
J Bioinform Comput Biol; 2022 Apr; 20(2):2150035. PubMed ID: 34923927
[TBL] [Abstract][Full Text] [Related]
10. Improving anti-cancer drug response prediction using multi-task learning on graph convolutional networks.
Liu H; Peng W; Dai W; Lin J; Fu X; Liu L; Liu L; Yu N
Methods; 2024 Feb; 222():41-50. PubMed ID: 38157919
[TBL] [Abstract][Full Text] [Related]
11. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
Peng W; Liu H; Dai W; Yu N; Wang J
Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
[TBL] [Abstract][Full Text] [Related]
12. Improving drug response prediction based on two-space graph convolution.
Peng W; Chen T; Liu H; Dai W; Yu N; Lan W
Comput Biol Med; 2023 May; 158():106859. PubMed ID: 37023539
[TBL] [Abstract][Full Text] [Related]
13. Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.
Park S; Soh J; Lee H
BMC Bioinformatics; 2021 May; 22(1):269. PubMed ID: 34034645
[TBL] [Abstract][Full Text] [Related]
14. Auto-HMM-LMF: feature selection based method for prediction of drug response via autoencoder and hidden Markov model.
Emdadi A; Eslahchi C
BMC Bioinformatics; 2021 Jan; 22(1):33. PubMed ID: 33509079
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.
Singha M; Pu L; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
BMC Cancer; 2022 Nov; 22(1):1211. PubMed ID: 36434556
[TBL] [Abstract][Full Text] [Related]
16. Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
Chiu YC; Chen HH; Zhang T; Zhang S; Gorthi A; Wang LJ; Huang Y; Chen Y
BMC Med Genomics; 2019 Jan; 12(Suppl 1):18. PubMed ID: 30704458
[TBL] [Abstract][Full Text] [Related]
17. Predicting anticancer hyperfoods with graph convolutional networks.
Gonzalez G; Gong S; Laponogov I; Bronstein M; Veselkov K
Hum Genomics; 2021 Jun; 15(1):33. PubMed ID: 34099048
[TBL] [Abstract][Full Text] [Related]
18. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
19. Predicting synthetic lethal interactions in human cancers using graph regularized self-representative matrix factorization.
Huang J; Wu M; Lu F; Ou-Yang L; Zhu Z
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):657. PubMed ID: 31870274
[TBL] [Abstract][Full Text] [Related]
20. Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution.
Peng W; Chen T; Dai W
IEEE J Biomed Health Inform; 2022 Mar; 26(3):1384-1393. PubMed ID: 34347616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
